Presilium Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
290
+8
+3% +$8.17K 0.05% 74
2026
Q1
$259K Buy
282
+19
+7% +$19.3K 0.05% 67
2025
Q4
$283K Sell
263
-215
-45% -$206K 0.05% 64
2025
Q3
$365K Buy
478
+43
+10% +$32K 0.07% 61
2025
Q2
$339K Buy
+435
New +$338K 0.07% 59

Other funds holding LLY

Presilium Private Wealth's LLY Position: Q2 2026 in Review

Presilium Private Wealth increased its Eli Lilly (LLY) stake by 2.8% in Q2 2026, buying an estimated $8.17K and bringing the position to 290 shares worth $348K. The position accounts for 0.05% of the portfolio, ranked #74.

Presilium Private Wealth first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. The position peaked at $365K in Q3 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Presilium Private Wealth held 290 shares of Eli Lilly worth $348K as of Q2 2026.
  • Presilium Private Wealth bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.05% of Presilium Private Wealth's portfolio in Q2 2026, its #74 holding.
  • Presilium Private Wealth first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • Presilium Private Wealth's Eli Lilly position peaked at $365K in Q3 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Presilium Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.